Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Luiting, HB"'
Autor:
Hinsenveld, Florentien J., Boormans, Joost L, van der Poel, Henk G, van der Schoot, Deric K E, Vis, André N, Aben, Katja K H, Arends, TJ, Ausems, PJ, Baselmans, D, Berger, CPAM, Berrens, A, Bickerstaffe, H, Bos, SD, Braam, M, Buddingh, KT, Claus, S, Dekker, K, van Doeveren, T, Einerhand, SMH, Fossion, LMCL, van Gennep, EJ, van Ginkel, N, Palacios, LA Grondhuis, Hermans, TJN, Hobijn, MM, van Huystee, SH, Jaspers-Valentijn, M, Klaver, OS, Koldewijn, EL, Korsten, L, Lenting, A, Lentjes, KJ, Luiting, HB, van der Meer, S., Nieuwenhuijzen, JA, Noordzij, MA, Nooter, RI, Notenboom, CAW, Oomen, RJA, van Roermund, JGH, de Rooij, J, Roshani, H, Schrier, BP, van der Slot, MA, Somford, DM, Stelwagen, PJ, Stroux, AMA, van der West, A, Wijsman, BP, Windt, WAKM, van Zanten, P, van Beek, Sytse C
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations February 2022 40(2):60-60
Autor:
de Vos II; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Luiting HB; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Publikováno v:
Journal of personalized medicine [J Pers Med] 2023 Apr 03; Vol. 13 (4). Date of Electronic Publication: 2023 Apr 03.
Autor:
Luiting HB; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: h.luiting@erasmusmc.nl., Remmers S; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Boevé ER; Department of Urology, Franciscus Hospital, Rotterdam, the Netherlands., Valdagni R; Prostate Cancer Program, Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Università degli Studi di Milano, Milan, Italy., Chiu PK; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China., Semjonow A; Department of Urology, Prostate Center, University Clinic Münster, Münster, Germany., Berge V; Department of Urology, Oslo University Hospital, Oslo, Norway., Tully KH; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany., Rannikko AS; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Staerman F; Department of Urology, Polyclinique Reims-Bezannes, Bezannes, France., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2022 Dec; Vol. 5 (6), pp. 651-658. Date of Electronic Publication: 2022 Apr 15.
Autor:
de Barros HA; Department of Urology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, the Netherlands. Electronic address: h.d.barros@nki.nl., Remmers S; Department of Urology, Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., Luiting HB; Department of Urology, Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., van Leenders GJLH; Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands., Bekers EM; Department of Pathology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Amin A; St Vincent's Prostate Cancer Centre, Darlinghurst, Australia; Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Haynes AM; Garvan Institute of Medical Research, Darlinghurst, Australia., Delprado W; Sonic Healthcare and Macquarie University, Sydney, Australia., Stricker PD; St Vincent's Prostate Cancer Centre, Darlinghurst, Australia; Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., van der Poel HG; Department of Urology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, the Netherlands; Department of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., van der Kwast TH; Laboratory Medicine Program and Princess Margaret Cancer Center, University Health Network, Toronto, Canada., van Leeuwen PJ; Department of Urology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, the Netherlands.
Publikováno v:
Urology [Urology] 2022 Oct; Vol. 168, pp. 156-164. Date of Electronic Publication: 2022 Jul 05.
Autor:
Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands. Electronic address: s.remmers@erasmusmc.nl., Hollemans E; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Nieboer D; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Luiting HB; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Helleman J; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands.
Publikováno v:
Annals of diagnostic pathology [Ann Diagn Pathol] 2022 Feb; Vol. 56, pp. 151842. Date of Electronic Publication: 2021 Oct 23.
Autor:
Luiting HB; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands. h.luiting@erasmusmc.nl., Remmers S; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands., Valdagni R; Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Boevé ER; Department of Urology, Sint Franciscus Hospital, Rotterdam, The Netherlands., Staerman F; Department of Urology, Polycliniques REIMS-BEZANNES, Reims, France., Rueb J; Department of Urology, Marien Hospital Herne, Herne, Germany., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Pickles T; Department of Radiation Oncology, Vancouver Center, BC Cancer, Vancouver, BC, Canada., Rannikko A; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland., Roobol MJ; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Dec; Vol. 24 (4), pp. 1048-1054. Date of Electronic Publication: 2021 Apr 08.
Autor:
Luiting HB; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Remmers S; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Center, VU University, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, VU University, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Donswijk M; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia., Rauscher I; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Van der Poel HG; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2021 Apr 29; Vol. 28, pp. 47-51. Date of Electronic Publication: 2021 Apr 29 (Print Publication: 2021).
Autor:
Meijer D; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Luiting HB; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., van Leeuwen PJ; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Remmers S; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Jansen BHE; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bodar YJL; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Witteveen T; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands., Schaake EE; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands., van der Poel HG; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Wondergem M; Noordwest Ziekenhuisgroep, Department of Nuclear Medicine, Alkmaar, The Netherlands., Busstra MB; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Nieuwenhuijzen JA; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Meijnen P; Amsterdam University Medical Center, VU University, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Brabander T; Erasmus University Medical Center, Department of Radiology & Nuclear Medicine, Rotterdam, The Netherlands., van Moorselaar RJA; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Hendrikse NH; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Clinical Pharmacology and Pharmacy, Amsterdam, The Netherlands., Oprea-Lager DE; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Roobol MJ; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Vis AN; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1100-1109. Date of Electronic Publication: 2020 Nov 18.
Autor:
Meijer D; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Luiting HB; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., van Leeuwen PJ; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Remmers S; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Jansen BHE; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bodar YJL; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Witteveen T; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands., Schaake EE; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands., van der Poel HG; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Wondergem M; Noordwest Ziekenhuisgroep, Department of Nuclear Medicine, Alkmaar, The Netherlands., Busstra MB; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Nieuwenhuijzen JA; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Meijnen P; Amsterdam University Medical Center, VU University, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Brabander T; Erasmus University Medical Center, Department of Radiology & Nuclear Medicine, Rotterdam, The Netherlands., van Moorselaar RJA; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands., Hendrikse NH; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam University Medical Center, VU University, Department of Clinical Pharmacology and Pharmacy, Amsterdam, The Netherlands., Oprea-Lager DE; Amsterdam University Medical Center, VU University, Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands., Roobol MJ; Erasmus University Medical Center, Department of Urology, Rotterdam, The Netherlands., Vis AN; Amsterdam University Medical Center, VU University, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.; The Netherlands Cancer Institute, Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1108-1109. Date of Electronic Publication: 2021 Jan 25.
Autor:
Luiting HB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Remmers S; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., Donswijk M; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bakker IL; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., Brabander T; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Stokkel M; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
The Journal of urology [J Urol] 2020 Sep; Vol. 204 (3), pp. 510. Date of Electronic Publication: 2020 Jun 26.